These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 2249187

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Alfa-2A interferon and 5-fluorouracil for advanced colorectal carcinoma: the Memorial Sloan-Kettering experience.
    Kemeny N, Younes A.
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):171-5. PubMed ID: 1557642
    [Abstract] [Full Text] [Related]

  • 3. 5-fluorouracil and interferon-alpha-2a in advanced colorectal cancer. Results of two treatment schedules.
    John WJ, Neefe JR, Macdonald JS, Cantrell J, Smith M.
    Cancer; 1993 Dec 01; 72(11):3191-5. PubMed ID: 8242541
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Phase III randomized study to compare interferon alfa-2a in combination with fluorouracil versus fluorouracil alone in patients with advanced colorectal cancer.
    Greco FA, Figlin R, York M, Einhorn L, Schilsky R, Marshall EM, Buys SS, Froimtchuk MJ, Schuller J, Schuchter L, Buyse M, Ritter L, Man A, Yap AK.
    J Clin Oncol; 1996 Oct 01; 14(10):2674-81. PubMed ID: 8874326
    [Abstract] [Full Text] [Related]

  • 6. Phase III randomized study of two fluorouracil combinations with either interferon alfa-2a or leucovorin for advanced colorectal cancer. Corfu-A Study Group.
    J Clin Oncol; 1995 Apr 01; 13(4):921-8. PubMed ID: 7707120
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A phase II randomised trial of 5-fluorouracil with or without interferon alpha-2a in advanced colorectal cancer.
    Piga A, Cascinu S, Latini L, Marcellini M, Bavosi M, Acito L, Bascioni R, Giustini L, Francini G, Pancotti A, Rossi G, Del Papa M, Carle F, Cellerino R.
    Br J Cancer; 1996 Sep 01; 74(6):971-4. PubMed ID: 8826868
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Fluorouracil modulation in colorectal cancer: lack of improvement with N -phosphonoacetyl- l -aspartic acid or oral leucovorin or interferon, but enhanced therapeutic index with weekly 24-hour infusion schedule--an Eastern Cooperative Oncology Group/Cancer and Leukemia Group B Study.
    O'Dwyer PJ, Manola J, Valone FH, Ryan LM, Hines JD, Wadler S, Haller DG, Arbuck SG, Weiner LM, Mayer RJ, Benson AB.
    J Clin Oncol; 2001 May 01; 19(9):2413-21. PubMed ID: 11331320
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical update on the role of fluorouracil and recombinant interferon alfa-2a in the treatment of colorectal carcinoma.
    Wadler S, Wiernik PH.
    Semin Oncol; 1990 Feb 01; 17(1 Suppl 1):16-21; discussion 38-41. PubMed ID: 2405491
    [Abstract] [Full Text] [Related]

  • 14. A phase I trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma.
    Kreuser ED, Hilgenfeld RU, Matthias M, Hoksch B, Boewer C, Oldenkott B, Knauf WU, Boese-Landgraf J, Schalhorn A, Zeitz M.
    Semin Oncol; 1992 Apr 01; 19(2 Suppl 3):197-203. PubMed ID: 1557647
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Phase II evaluation of fluorouracil and recombinant alpha-2a-interferon in previously untreated patients with pancreatic adenocarcinoma.
    Pazdur R, Ajani JJ, Abbruzzese JL, Belt RJ, Dakhil SR, Dubovsky D, Graham S, Pilat S, Winn R, Levin B.
    Cancer; 1992 Oct 15; 70(8):2073-6. PubMed ID: 1394037
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.